Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Malignant Melanoma

Free Subscription Articles published in Eur J Dermatol Retrieve available abstracts of 55 articles: HTML format

Single Articles

December 2023
1. SONG T, Tan C, Liu Y, Xue YN, et al
   Dermoscopic and reflectance confocal microscopy features of Netherton syndrome.
   Eur J Dermatol. 2023;33:696-697.
   PubMed    
   
   
   
2. LANGBOUR C, Law-Wan J, Ben-Saad R, Zaragoza J, et al
   Intramedullary spinal cord metastasis: a rare complication of malignant melanoma.
   Eur J Dermatol. 2023;33:694-696.
   PubMed    
   
   
   October 2023
3. FUKUCHI K, Shimauchi T, Fujiyama T, Ito T, et al
   A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment.
   Eur J Dermatol. 2023;33:550-551.
   PubMed    
   
   
   
4. KIM PJ, Lansang RP, Ko E, Abu-Hilal M, et al
   Incidence of melanoma and non-melanoma skin cancer in patients with celiac disease: a systematic review and meta-analysis.
   Eur J Dermatol. 2023;33:506-513.
   PubMed     Abstract available
   
   
   
5. VAN DIEREN L, Amar JZ, Geurs N, Quisenaerts T, et al
   Unveiling the power of convolutional neural networks in melanoma diagnosis.
   Eur J Dermatol. 2023;33:495-505.
   PubMed     Abstract available
   
   
   June 2023
6. SAMELA T, Fania L, Sampogna F, Mastroeni S, et al
   Incidence of keratinocyte carcinomas in Italy: an exercise in indirect estimation based on melanoma data.
   Eur J Dermatol. 2023;33:230-234.
   PubMed     Abstract available
   
   
   
7. IBRAHIM N, Ali SR, Dobbs TD, Gibson AGJ, et al
   The incidence of non-melanoma skin cancer in the UK and the Republic of Ireland: a systematic review.
   Eur J Dermatol. 2023;33:218-229.
   PubMed     Abstract available
   
   
   April 2023
8. GARCIA-PIQUERAS P, Aviles-Izquierdo JA
   Clues in Dermoscopy. Epidermotropic cutaneous malignant melanoma metastases: a description of 25 cases.
   Eur J Dermatol. 2023;33:190-192.
   PubMed    
   
   
   
9. PIROTH M, Goronflot T, Samaran R, Varey E, et al
   Panniculitis does not predict clinical response in patients with advanced melanoma under targeted therapy.
   Eur J Dermatol. 2023;33:126-136.
   PubMed     Abstract available
   
   
   
10. BELLINATO F, Moar A, Rosina P, Gisondi P, et al
    Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma.
    Eur J Dermatol. 2023;33:121-125.
    PubMed     Abstract available
    
    
    
11. CHARPENTIER C, Riche VP, Nguyen JM, Guile R, et al
    Analysis of cost-effectiveness of chemotherapeutic agents and new therapies for the management of unresectable and metastatic melanoma.
    Eur J Dermatol. 2023;33:81-86.
    PubMed     Abstract available
    
    
    
12. FRENARD C, Blanchet K, Lecerf P, Varey E, et al
    Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma.
    Eur J Dermatol. 2023;33:75-80.
    PubMed     Abstract available
    
    
    November 2022
13. ECKARDT J, Behrens V, Kofler K, Forchhammer S, et al
    The impact of haematoxylin-eosin staining and immunohistochemistry of lentigo maligna and lentigo maligna melanoma margins on local recurrence.
    Eur J Dermatol. 2022;32:750-755.
    PubMed     Abstract available
    
    
    
14. ZOUTENDIJK J, Siem D, Argenziano G, Forsea AM, et al
    The daily use of dermoscopy in the Netherlands.
    Eur J Dermatol. 2022;32:736-742.
    PubMed     Abstract available
    
    
    
15. L'ORPHELIN JM, Le Naour S, Dalle S, Varey E, et al
    Epidemiology and characteristics of acral lentiginous melanoma compared to lentigo melanoma in France: a multicentric retrospective study from the French cohort RIC-Mel database.
    Eur J Dermatol. 2022;32:691-697.
    PubMed     Abstract available
    
    
    
16. RICCI F, Fania L, Antonelli F, Ricci F, et al
    Melanoma on tattoos: a case study and review of the literature.
    Eur J Dermatol. 2022;32:703-708.
    PubMed     Abstract available
    
    
    
17. PAPANIKOLAOU ES, Sampogna F, Fania L, Di Lella G, et al
    Quality of life in caregivers of melanoma patients.
    Eur J Dermatol. 2022;32:698-702.
    PubMed     Abstract available
    
    
    September 2022
18. SPURNY-DWORAK J, Steiner A, Breier F, Stella A, et al
    Effects of the COVID-19 pandemic on the diagnosis of malignant melanoma: a retrospective study.
    Eur J Dermatol. 2022;32:615-617.
    PubMed     Abstract available
    
    
    July 2022
19. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey
    Eur J Dermatol. 2022;31:521-529.
    PubMed     Abstract available
    
    
    
20. GAMO-VILLEGAS R, Floristan-Muruzabal U, Pampin-Franco A, Martin-Alcalde J, et al
    Dermoscopic changes in 22 extrafacial in situ and invasive lentiginous melanomas
    Eur J Dermatol. 2022;32:516-521.
    PubMed     Abstract available
    
    
    May 2022
21. YANG L, Wang T, Liu YH
    A Chinese case of amelanotic lentigo maligna melanoma
    Eur J Dermatol. 2022;32:410-411.
    PubMed    
    
    
    April 2022
22. SUHONEN V, Siiskonen H, Suni M, Rummukainen J, et al
    Malignant and in situ subtypes of melanoma are associated with basal and squamous cell carcinoma and its precancerous lesions
    Eur J Dermatol. 2022;32:187-194.
    PubMed     Abstract available
    
    
    February 2022
23. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence in situ hybridization and mutation analysis.
    Eur J Dermatol. 2022 Feb 15. pii: ejd.2022.4208. doi: 10.1684/ejd.2022.4208.
    PubMed    
    
    
    
24. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022 Feb 11. pii: ejd.2022.4198. doi: 10.1684/ejd.2022.4198.
    PubMed    
    
    
    January 2022
25. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence.
    Eur J Dermatol. 2022;32:134-135.
    PubMed    
    
    
    
26. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022;32:126-127.
    PubMed    
    
    
    
27. SUYAMA T, Nishimura T, Yokoyama M, Matsuki Y, et al
    Paediatric spitzoid melanoma diagnosed with the aid of fluorescence.
    Eur J Dermatol. 2022;32:134-135.
    PubMed    
    
    
    
28. AMABILE S, Tonella L, Rubatto M, Argenziano G, et al
    Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study.
    Eur J Dermatol. 2022;32:126-127.
    PubMed    
    
    
    December 2021
29. DUARTE AF, Sousa-Pinto B, Azevedo LF, Barros AM, et al
    Clinical ABCDE rule for early melanoma detection.
    Eur J Dermatol. 2021;31:771-778.
    PubMed     Abstract available
    
    
    
30. LACOMBE M, Bedane C, Delaumenie S, Bernard P, et al
    Nivolumab-induced multiple morphea associated with eosinophilic fasciitis.
    Eur J Dermatol. 2021;31:844-846.
    PubMed    
    
    
    November 2021
31. RUBIO-CASADEVALL J, Carbo-Bague A, Puigdemont M, Osca-Gelis G, et al
    Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor.
    Eur J Dermatol. 2021 Nov 17. pii: ejd.2021.4136. doi: 10.1684/ejd.2021.4136.
    PubMed     Abstract available
    
    
    
32. BUJA A, De Luca G, Zorzi M, Carpin E, et al
    Quality management of cutaneous melanoma: impact on short-term outcomes and costs.
    Eur J Dermatol. 2021 Nov 17. pii: ejd.2021.4149. doi: 10.1684/ejd.2021.4149.
    PubMed     Abstract available
    
    
    October 2021
33. MAEDA T, Hiura A, Uehara J, Toyoshima R, et al
    Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia.
    Eur J Dermatol. 2021 Oct 7. pii: ejd.2021.4139. doi: 10.1684/ejd.2021.4139.
    PubMed    
    
    
    
34. GARCIA-PIQUERAS P, Aviles-Izquierdo JA, Almodovar-Real A, Nieto-Benito LM, et al
    Clues in dermoscopy: White and yellow structures in balloon cell melanoma.
    Eur J Dermatol. 2021;31:676-677.
    PubMed    
    
    
    
35. NEUBERGER A, Menzer C, Volk N, Enk AH, et al
    Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
    Eur J Dermatol. 2021;31:609-615.
    PubMed     Abstract available
    
    
    August 2021
36. SENDIN-MARTIN M, Duran-Romero AJ, Martin-Carrasco P, Conejo-Mir J, et al
    Mortality associated with non-melanoma skin cancer in Spain from 1979 to 2018: trends and age-adjusted rates.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4110. doi: 10.1684/ejd.2021.4110.
    PubMed     Abstract available
    
    
    
37. ARAUJO BLC, De Oliveira JL, Correa FM, Fontes LES, et al
    General anaesthesia versus other types of anaesthesia in patients undergoing surgery for treatment of cutaneous melanoma: a systematic review and meta-analysis.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4109. doi: 10.1684/ejd.2021.4109.
    PubMed     Abstract available
    
    
    
38. TEUSCHER M, Diehl K, Schaarschmidt ML, Weilandt J, et al
    Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4098. doi: 10.1684/ejd.2021.4098.
    PubMed     Abstract available
    
    
    
39. BOADA A, Tejera-Vaquerizo A, Requena C, Manrique-Silva E, et al
    Association between melanoma thickness and clinical and demographic characteristics.
    Eur J Dermatol. 2021 Aug 26. pii: ejd.2021.4096. doi: 10.1684/ejd.2021.4096.
    PubMed     Abstract available
    
    
    
40. DONZEL M, Harou O, Skowron F, Dalle S, et al
    Acral lentiginous melanoma with HER2/ErbB2 amplification.
    Eur J Dermatol. 2021;31:588-590.
    PubMed    
    
    
    
41. GEDEAH C, Damsin T, Absil G, Somja J, et al
    The impact of COVID-19 on the new diagnoses of melanoma.
    Eur J Dermatol. 2021;31:565-567.
    PubMed    
    
    
    
42. SAMARAN R, L'Orphelin JM, Dreno B, Rat C, et al
    Interest in artificial intelligence for the diagnosis of non-melanoma skin cancer: a survey among French general practitioners.
    Eur J Dermatol. 2021;31:457-462.
    PubMed     Abstract available
    
    
    June 2021
43. ARNE V, Canan G, Marjan G
    A narrative review on the outcome of primary cutaneous melanomas arising in solid organ transplant recipients.
    Eur J Dermatol. 2021 Jun 2. pii: ejd.2021.4067. doi: 10.1684/ejd.2021.4067.
    PubMed     Abstract available
    
    
    
44. POZSGAI M, Nemeth K, Olah P, Gyulai R, et al
    The significance of imaging examinations during follow-up for malignant melanoma.
    Eur J Dermatol. 2021;31:357-363.
    PubMed     Abstract available
    
    
    
45. MASSON L, Poizeau F
    sQuiz your knowledge! A cutaneous nodule in an HIV-positive man returning from Thailand.
    Eur J Dermatol. 2021;31:436-437.
    PubMed    
    
    
    April 2021
46. BANCALARI B, Ferrer-Guillen S, Tejera-Vaquerizo A, Requena C, et al
    Longitudinal study of prognostic factors for localized cutaneous melanoma in patients who have been disease-free for five years.
    Eur J Dermatol. 2021 Apr 19. pii: ejd.2021.4022. doi: 10.1684/ejd.2021.4022.
    PubMed     Abstract available
    
    
    
47. SCARD C, Nguyen JM, Varey E, Moustaghfir I, et al
    Cardiac adverse events associated with anti-PD-1 therapy in patients treated for advanced melanoma: relevance of dosing troponin T levels.
    Eur J Dermatol. 2021 Apr 2. pii: ejd.2021.4009. doi: 10.1684/ejd.2021.4009.
    PubMed     Abstract available
    
    
    
48. JOVIC A, Tiodorovic D, Popovic D, Vidovic N, et al
    Multiple eruptive squamous cell carcinomas: a possible clinical sign in melanoma patients treated with vemurafenib.
    Eur J Dermatol. 2021;31:279-280.
    PubMed    
    
    
    
49. KACZMARCZYK R, King F, Tizek L, Biedermann T, et al
    Visualising the past to plan the future: a network analysis of the largest European dermatology conference.
    Eur J Dermatol. 2021;31:161-169.
    PubMed     Abstract available
    
    
    
50. RODRIGUEZ-LOMBA E, Lozano-Masdemont B, Sanchez-Herrero A, Suarez-Fernandez R, et al
    Dermsurgery: Reconstruction of a large dorsal hand defect with a dermal substitute matrix.
    Eur J Dermatol. 2021;31:302-304.
    PubMed    
    
    
    March 2021
51. MILLAN-ESTEBAN D, Garcia-Casado Z, Manrique-Silva E, Viros A, et al
    Distribution and clinical role of KIT gene mutations in melanoma according to subtype: a study of 492 Spanish patients.
    Eur J Dermatol. 2021 Mar 1. pii: ejd.2021.3971. doi: 10.1684/ejd.2021.3971.
    PubMed     Abstract available
    
    
    February 2021
52. RUSSO I, Filoni A, Alaibac M
    Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.
    Eur J Dermatol. 2021 Feb 12. pii: ejd.2020.3958. doi: 10.1684/ejd.2020.3958.
    PubMed    
    
    
    December 2020
53. LUDWIG SV, F Cheng P, Mangana J, Braun R, et al
    Survival and therapeutic response in patients with melanoma of unknown and known primary: a single-centre retrospective analysis.
    Eur J Dermatol. 2020;30:699-709.
    PubMed     Abstract available
    
    
    November 2020
54. MORA-FERNANDEZ V, Boada A, Manzano JL, Jaka A, et al
    Locally advanced head and neck squamous cell carcinoma and melanoma simultaneously treated with pembrolizumab: an unusual situation.
    Eur J Dermatol. 2020 Nov 24. pii: ejd.2020.3911. doi: 10.1684/ejd.2020.3911.
    PubMed    
    
    
    October 2020
55. GRAN F, Weber J, Schummer P, Kneitz H, et al
    Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma.
    Eur J Dermatol. 2020;30:629-631.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.